Activation of murine T-cells via phospholipase-C gamma 1-associated protein tyrosine phosphorylation is reduced with aging. 1995

A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
Department of Comparative Medicine, University of Washington, Seattle, USA.

Cross-linking of the T-cell receptor (CD3) induces activation of tyrosine kinases and the subsequent phosphorylation of intracellular protein substrates. We examined whether early events in signal transduction through CD3 or CD3 x CD4 receptor ligation were altered in aged murine T-lymphocytes. Both calcium mobilization and tyrosine phosphorylation of phospholipase C gamma 1 (PLC gamma 1) were decreased in T-lymphocytes from old mice. In addition, there was less tyrosine phosphorylation of a 35/36 kDa protein both in whole cell lysates and in PLC gamma 1 immunoprecipitates from old mice. This 35/36 kDa phosphoprotein binds specifically to the SH2 domains of PLC gamma 1. Using a fusion protein containing the SH2 domains of PLC gamma 1 and human IgG1 heavy chain, we identified three additional proteins that bind to the SH2 domains which were tyrosine phosphorylated following CD3 x CD4 ligation to a lesser degree with age. The tyrosine phosphorylation of two phosphoproteins binding to a fusion protein consisting of the SH2 domains of GAP (ras GTPase-activating protein) and human IgG1 heavy chain was also reduced with aging. The observed binding to SH2 domains was thiol redox sensitive. Thus, decreases in antioxidants with age may be responsible for inhibitory effects on PLC gamma 1-phosphatidylinositol signaling through redox regulation of tyrosine phosphoproteins.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010750 Phosphoproteins Phosphoprotein
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
June 1996, Molecular and cellular biology,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
January 1993, Advances in second messenger and phosphoprotein research,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
July 2004, The Journal of biological chemistry,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
April 1991, Biochemical Society transactions,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
July 1991, Proceedings of the National Academy of Sciences of the United States of America,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
July 1991, The Journal of biological chemistry,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
December 1992, The Journal of experimental medicine,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
November 1993, Journal of immunology (Baltimore, Md. : 1950),
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
April 1999, Chemistry and physics of lipids,
A Grossmann, and P S Rabinovitch, and T J Kavanagh, and J C Jinneman, and L K Gilliland, and J A Ledbetter, and S B Kanner
November 1993, The Journal of experimental medicine,
Copied contents to your clipboard!